Aidigong Maternal & Child Health Limited

SEHK:286 Stock Report

Market Cap: HK$328.6m

Aidigong Maternal & Child Health Past Earnings Performance

Past criteria checks 0/6

Aidigong Maternal & Child Health's earnings have been declining at an average annual rate of -17.5%, while the Healthcare industry saw earnings growing at 9% annually. Revenues have been growing at an average rate of 1.3% per year.

Key information

-17.5%

Earnings growth rate

-14.1%

EPS growth rate

Healthcare Industry Growth11.3%
Revenue growth rate1.3%
Return on equity-25.5%
Net Margin-37.0%
Last Earnings Update30 Jun 2024

Recent past performance updates

Recent updates

Aidigong Maternal & Child Health Limited's (HKG:286) 44% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio

Nov 09
Aidigong Maternal & Child Health Limited's (HKG:286) 44% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio

Pinning Down Aidigong Maternal & Child Health Limited's (HKG:286) P/S Is Difficult Right Now

Sep 25
Pinning Down Aidigong Maternal & Child Health Limited's (HKG:286) P/S Is Difficult Right Now

Investors Don't See Light At End Of Aidigong Maternal & Child Health Limited's (HKG:286) Tunnel And Push Stock Down 26%

Jun 06
Investors Don't See Light At End Of Aidigong Maternal & Child Health Limited's (HKG:286) Tunnel And Push Stock Down 26%

Take Care Before Jumping Onto Aidigong Maternal & Child Health Limited (HKG:286) Even Though It's 28% Cheaper

Mar 22
Take Care Before Jumping Onto Aidigong Maternal & Child Health Limited (HKG:286) Even Though It's 28% Cheaper

A Look At The Fair Value Of Aidigong Maternal & Child Health Limited (HKG:286)

Jul 06
A Look At The Fair Value Of Aidigong Maternal & Child Health Limited (HKG:286)

Aidigong Maternal & Child Health Limited (HKG:286) Looks Inexpensive After Falling 28% But Perhaps Not Attractive Enough

Jun 14
Aidigong Maternal & Child Health Limited (HKG:286) Looks Inexpensive After Falling 28% But Perhaps Not Attractive Enough

Calculating The Intrinsic Value Of Aidigong Maternal & Child Health Limited (HKG:286)

Mar 27
Calculating The Intrinsic Value Of Aidigong Maternal & Child Health Limited (HKG:286)

Is Aidigong Maternal & Child Health Limited (HKG:286) Trading At A 24% Discount?

Dec 21
Is Aidigong Maternal & Child Health Limited (HKG:286) Trading At A 24% Discount?

Is Aidigong Maternal & Child Health (HKG:286) Using Debt In A Risky Way?

Oct 13
Is Aidigong Maternal & Child Health (HKG:286) Using Debt In A Risky Way?

Estimating The Fair Value Of Aidigong Maternal & Child Health Limited (HKG:286)

Sep 02
Estimating The Fair Value Of Aidigong Maternal & Child Health Limited (HKG:286)

Aidigong Maternal & Child Health (HKG:286) Has A Somewhat Strained Balance Sheet

Jun 29
Aidigong Maternal & Child Health (HKG:286) Has A Somewhat Strained Balance Sheet

Aidigong Maternal & Child Health (HKG:286) Use Of Debt Could Be Considered Risky

Aug 31
Aidigong Maternal & Child Health (HKG:286) Use Of Debt Could Be Considered Risky

Do Institutions Own Aidigong Maternal & Child Health Limited (HKG:286) Shares?

Feb 21
Do Institutions Own Aidigong Maternal & Child Health Limited (HKG:286) Shares?

Is Aidigong Maternal & Child Health Limited's (HKG:286) Stock Price Struggling As A Result Of Its Mixed Financials?

Jan 17
Is Aidigong Maternal & Child Health Limited's (HKG:286) Stock Price Struggling As A Result Of Its Mixed Financials?

Aidigong Maternal & Child Health's(HKG:286) Share Price Is Down 14% Over The Past Three Years.

Dec 12
Aidigong Maternal & Child Health's(HKG:286) Share Price Is Down 14% Over The Past Three Years.

Revenue & Expenses Breakdown

How Aidigong Maternal & Child Health makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

SEHK:286 Revenue, expenses and earnings (HKD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 24522-1932610
31 Mar 24538-1852590
31 Dec 23555-1772570
30 Sep 23606-1522570
30 Jun 23658-1272570
31 Mar 23669-1462630
31 Dec 22680-1652690
30 Sep 22664-1232250
30 Jun 22647-801810
31 Mar 22645-371760
31 Dec 2164351710
30 Sep 21622-1891780
30 Jun 21601-3841860
31 Mar 21601-3831780
31 Dec 20601-3811710
30 Sep 20653-1721690
30 Jun 20704371670
31 Mar 20657241450
31 Dec 19611111230
30 Sep 194923920
30 Jun 19374-5600
31 Mar 19376-1630
31 Dec 183772650
30 Sep 184522640
30 Jun 185283640
31 Mar 185012540
31 Dec 174751450
30 Sep 174968430
30 Jun 1751714410
31 Mar 1753628450
31 Dec 1655542490
30 Sep 1658351450
30 Jun 1661059410
31 Mar 1657047370
31 Dec 1553034320
30 Jun 1548527380
31 Mar 1542224350
31 Dec 1436020330
30 Jun 1417-10180
31 Mar 1413-6150
31 Dec 139-3120

Quality Earnings: 286 is currently unprofitable.

Growing Profit Margin: 286 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 286 is unprofitable, and losses have increased over the past 5 years at a rate of 17.5% per year.

Accelerating Growth: Unable to compare 286's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 286 is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (-16.9%).


Return on Equity

High ROE: 286 has a negative Return on Equity (-25.5%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/18 00:58
End of Day Share Price 2024/12/18 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Aidigong Maternal & Child Health Limited is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Zhuonan XuChina International Capital Corporation Limited
Chen Tung FungOriental Patron Securities Limited
Zhang LiuTianfeng Securities Brokerage Co., Ltd